SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-019503
Filing Date
2020-07-31
Accepted
2020-07-31 08:42:20
Documents
108
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2020_chinasxtpharma.htm 20-F 1439482
2 AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION f20f2020ex1-2_chinasxtpha.htm EX-1.2 334369
3 CERTIFICATION f20f2020ex12-1_chinasxtpha.htm EX-12.1 10379
4 CERTIFICATION f20f2020ex12-2_chinasxtpha.htm EX-12.2 10605
5 CERTIFICATION f20f2020ex13-1_chinasxtpha.htm EX-13.1 4133
6 CONSENT OF INDEPENDENT AUDITORS f20f2020ex23-1_chinasxtpha.htm EX-23.1 3303
7 GRAPHIC image_001.jpg GRAPHIC 27925
8 GRAPHIC image_002.jpg GRAPHIC 64613
9 GRAPHIC image_003.jpg GRAPHIC 20714
10 GRAPHIC ex23-1_001.jpg GRAPHIC 6019
  Complete submission text file 0001213900-20-019503.txt   6256837

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE sxtc-20200331.xml EX-101.INS 790247
12 XBRL SCHEMA FILE sxtc-20200331.xsd EX-101.SCH 66803
13 XBRL CALCULATION FILE sxtc-20200331_cal.xml EX-101.CAL 75023
14 XBRL DEFINITION FILE sxtc-20200331_def.xml EX-101.DEF 217554
15 XBRL LABEL FILE sxtc-20200331_lab.xml EX-101.LAB 353777
16 XBRL PRESENTATION FILE sxtc-20200331_pre.xml EX-101.PRE 354880
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-38773 | Film No.: 201063700
SIC: 2834 Pharmaceutical Preparations